Real-world outcomes of ledipasvir/sofosbuvir in treatment-naive patients with hepatitis C

The American journal of managed care

Volumn 22, Issue 6, 2016, Pages SP205-SP211

  Younossi, Zobair M ^b   Park, Haesuk ^b   Gordon, Staurt C ^b   Ferguson, John R ^b   Ahmed, Aijaz ^b   Dieterich, Douglas ^b   Saab, Sammy ^a  

^a Center for Integrated Research   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BENZIMIDAZOLE DERIVATIVE; FLUORENE DERIVATIVE; LEDIPASVIR, SOFOSBUVIR DRUG COMBINATION; URIDINE PHOSPHATE;

ADULT; AGED; ANALOGS AND DERIVATIVES; CHRONIC HEPATITIS C; CLINICAL TRIAL (TOPIC); COMBINATION DRUG THERAPY; COST BENEFIT ANALYSIS; ECONOMICS; FEMALE; HUMAN; LONGITUDINAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY (TOPIC); OUTCOME ASSESSMENT; PROSPECTIVE STUDY; REGISTER; STATISTICS AND NUMERICAL DATA; SUSTAINED VIROLOGIC RESPONSE; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTIVIRAL AGENTS; BENZIMIDAZOLES; CLINICAL TRIALS AS TOPIC; COST-BENEFIT ANALYSIS; DRUG THERAPY, COMBINATION; FEMALE; FLUORENES; HEPATITIS C, CHRONIC; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; REGISTRIES; SUSTAINED VIROLOGIC RESPONSE; UNITED STATES; URIDINE MONOPHOSPHATE; YOUNG ADULT;

EID: 85013959995     PISSN: None     EISSN: 19362692     Source Type: Journal    
DOI: None     Document Type: Article

References (0)